Presentation by Mike Kenny, Associate Commercial Director, Innovation Agency at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
The purpose of this event is to provide information to enable businesses to decide if the Smart Sustainable Plastics Packaging Challenge FeasibilityStudies competition (we will also recap on the currently open Demonstrator Round 1 or Feasibility Studies for Demonstrators Competition of SSPP so attendees can decide which is appropriate for them).
Innovate UK (UKRI) and the Knowledge Transfer Network are hosting a briefing event for third competition of the Smart Sustainable Plastics Packaging Challenge:
Feasibility Studies
The competition is due to open for applications on 13th January, more details will be published on the competitions page shortly.
As part of the Clean Growth Grand Challenge within the Government’s Industrial Strategy, a £60m Smart Sustainable Plastic Packaging Challenge was announced in Summer 2019 which is expected to be matched by funding of up to £149 million from industry.
The challenge will deliver strategic leadership and a co-ordinated programme of research and innovation for the design, production, supply, recovery and recycling of plastic packaging across the entire value chain.
The Opportunity:
Innovate UK, part of UK Research and Innovation, will invest up to £1 million from the Smart Sustainable Plastic Packaging Programme to fund feasibility projects for solutions to create a more circular economy for plastic packaging. Projects must show how they will deliver a more circular plastics packaging supply chain and deliver the targets of the UK Plastics Pact.
Projects are welcome that trial smart and sustainable packaging innovation across 4 themes:
- Materials
- Design
- Technology or process
- Business model or behaviour change
This Briefing Event will provide:
• an opportunity to hear about the scope of the competition in more detail from the competition team
• opportunities to network and develop ideas and partnerships for the competition
• an opportunity to meet and explore ideas with UKRI and wider stakeholders
Find out more: https://ktn-uk.co.uk/events/iscf-smart-sustainable-plastic-packaging-competition-briefing-feasibility-studies-enabling-research
Amiram Porath: Translational Research as Tool for Academy Technology TransferCUBCCE Conference
One of the main barriers for technology transfer from academy to the industry is the basic not applicable enough nature of the academic research results. Maturing that knowdge via translational research allows the research results, the knowledge to reach the decision point, when industry can evaluate and decide whether to take it or not. The ISraeli Innovation Authority has been operating in recent years two such national programs, KAMIN and NUFAR to help the transfer on knowledge from academy to industry. The lessons learnt from the programs are presented showing that the effort is worth while.
Day 2: Open Science and Big Data in support of measuring R&I Indicators. Panel discussion.
https://www.openaire.eu/research-policy-monitoring-in-the-era-of-open-science-and-big-data-the-what-indicators-and-the-how-infrastructures
Engage with...Lincoln Institute for Agri-Food TechnologyKTN
The University of Lincoln is one of the UK leading developers of agri-robotic technologies. The Lincoln Institute for Agri-Food Technology specialises in robotic systems to support autonomous crop harvesting and electrification of farming. These are technologies which are of crucial and urgent importance post-COVID-19.
The sector needs robotic systems to reduce reliance on manual labour. In addition, farming has a high dependency on off-road and typically diesel-powered vehicles. The sector needs to transition to electric powered vehicles; this may involve a move towards smaller fleets of lightweight electric-powered vehicles or larger machines.
The presentation by Prof Simon Pearson highlighted opportunities for the UK manufacturing sector to engage in this transformation of the food production system.
Study of Market Potential and Prospective Partners in India for hand-held qPC...Aagami, Inc.
Client:
Innovation Center of a New Zealand University focused on Health Sciences
Client Need:
A mobile, lightweight molecular diagnostic technology and device was developed at the University. Its Innovation center wanted to study the market potential in India.
As per Aagami’s suggestion, client agreed to include regulatory overview and potential partners in the study.
Results:
The report helped the University in determining conclusively on India market initiative.
Pleased with the report, the University appointed Aagami to find a licensing partner in India
First eStandards conference Panel of the European SDO Platformchronaki
Introduction to panel where Standards Developing Organization and National Competence Centers discuss the scope of the European SDO platform reflecting on earlier presentations.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
Presentation by Mike Kenny, Associate Commercial Director, Innovation Agency at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
The purpose of this event is to provide information to enable businesses to decide if the Smart Sustainable Plastics Packaging Challenge FeasibilityStudies competition (we will also recap on the currently open Demonstrator Round 1 or Feasibility Studies for Demonstrators Competition of SSPP so attendees can decide which is appropriate for them).
Innovate UK (UKRI) and the Knowledge Transfer Network are hosting a briefing event for third competition of the Smart Sustainable Plastics Packaging Challenge:
Feasibility Studies
The competition is due to open for applications on 13th January, more details will be published on the competitions page shortly.
As part of the Clean Growth Grand Challenge within the Government’s Industrial Strategy, a £60m Smart Sustainable Plastic Packaging Challenge was announced in Summer 2019 which is expected to be matched by funding of up to £149 million from industry.
The challenge will deliver strategic leadership and a co-ordinated programme of research and innovation for the design, production, supply, recovery and recycling of plastic packaging across the entire value chain.
The Opportunity:
Innovate UK, part of UK Research and Innovation, will invest up to £1 million from the Smart Sustainable Plastic Packaging Programme to fund feasibility projects for solutions to create a more circular economy for plastic packaging. Projects must show how they will deliver a more circular plastics packaging supply chain and deliver the targets of the UK Plastics Pact.
Projects are welcome that trial smart and sustainable packaging innovation across 4 themes:
- Materials
- Design
- Technology or process
- Business model or behaviour change
This Briefing Event will provide:
• an opportunity to hear about the scope of the competition in more detail from the competition team
• opportunities to network and develop ideas and partnerships for the competition
• an opportunity to meet and explore ideas with UKRI and wider stakeholders
Find out more: https://ktn-uk.co.uk/events/iscf-smart-sustainable-plastic-packaging-competition-briefing-feasibility-studies-enabling-research
Amiram Porath: Translational Research as Tool for Academy Technology TransferCUBCCE Conference
One of the main barriers for technology transfer from academy to the industry is the basic not applicable enough nature of the academic research results. Maturing that knowdge via translational research allows the research results, the knowledge to reach the decision point, when industry can evaluate and decide whether to take it or not. The ISraeli Innovation Authority has been operating in recent years two such national programs, KAMIN and NUFAR to help the transfer on knowledge from academy to industry. The lessons learnt from the programs are presented showing that the effort is worth while.
Day 2: Open Science and Big Data in support of measuring R&I Indicators. Panel discussion.
https://www.openaire.eu/research-policy-monitoring-in-the-era-of-open-science-and-big-data-the-what-indicators-and-the-how-infrastructures
Engage with...Lincoln Institute for Agri-Food TechnologyKTN
The University of Lincoln is one of the UK leading developers of agri-robotic technologies. The Lincoln Institute for Agri-Food Technology specialises in robotic systems to support autonomous crop harvesting and electrification of farming. These are technologies which are of crucial and urgent importance post-COVID-19.
The sector needs robotic systems to reduce reliance on manual labour. In addition, farming has a high dependency on off-road and typically diesel-powered vehicles. The sector needs to transition to electric powered vehicles; this may involve a move towards smaller fleets of lightweight electric-powered vehicles or larger machines.
The presentation by Prof Simon Pearson highlighted opportunities for the UK manufacturing sector to engage in this transformation of the food production system.
Study of Market Potential and Prospective Partners in India for hand-held qPC...Aagami, Inc.
Client:
Innovation Center of a New Zealand University focused on Health Sciences
Client Need:
A mobile, lightweight molecular diagnostic technology and device was developed at the University. Its Innovation center wanted to study the market potential in India.
As per Aagami’s suggestion, client agreed to include regulatory overview and potential partners in the study.
Results:
The report helped the University in determining conclusively on India market initiative.
Pleased with the report, the University appointed Aagami to find a licensing partner in India
First eStandards conference Panel of the European SDO Platformchronaki
Introduction to panel where Standards Developing Organization and National Competence Centers discuss the scope of the European SDO platform reflecting on earlier presentations.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
ISCF Application of whole Genome Sequencing approaches to CancerKTN
Innovate UK, part of UK Research and Innovation, will invest up to £5.4 million of the Industrial Strategy Challenge Fund as part of the Data to Early Diagnosis and Precision Medicine Challenge.
The aim of this competition, which opens on 7 October and closes on 22 January is to support projects that use whole genome sequencing to analyse cancers. This can be through the manipulation of existing whole genome data, through the collection of new sequence data or through a combination of both.
Possible approaches include but are not limited to:
• the development of new analytical or reporting tools for clinical decision support
• the identification of molecular signatures that allow for new or improved targeting of therapies
• the identification of new therapeutic targets
• new genetic signatures that can be used clinically, such as markers that support repurposing of drugs or a personalised approach to patient management
• the comparative assessment of alternative assay methods in parallel with whole genome sequencing
Find out more about the Health Special Interest Group at https://ktn-uk.co.uk/interests/health
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
Industrial Strategy Challenge Fund Next Generation Services CR&D Briefing SlidesKTN
UK Research and Innovation will invest up to £12 million in innovation projects to support the application of artificial intelligence (AI) and data technologies. Projects should aim to transform the 3 target sectors:
Accountancy
Insurance
Legal services
Find out more: https://ktn-uk.co.uk/funding/transforming-accountancy-insurance-and-legal-services-with-ai-and-data-small-projects-strand
Agri-Tech Catalyst Round 10 - Food Systems and NutritionKTN
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Karen Livingstone, Director of Innovation Exchange and SBRI Healthcare, NHS England: Transforming Health and Social Care Services - The Innovation Exchange and SBRI Healthcare at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
Industrial Strategy:Prospering from the energy revolution - Rob Saunders, In...KTN
Key technology components for local energy systems
briefing event
The webcast recording is now available. Click here to watch it: https://www.youtube.com/watch?v=gPyTb_-qhgo
Find out more about Energy interest group at https://ktn-uk.co.uk/interests/energy
Join the Energy LinkedIn group at https://www.linkedin.com/groups/3380615/
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
WEBINAR: ISCF transforming foundation industries: fast start projects - Compe...KTN
Innovate UK will fund up to £5m in R&D and Innovation projects for the foundation industries (cement, ceramics, chemicals, paper, glass and metals). These will be cross-sector, collaborative, fast start, short duration, industrial research and development (R&D) projects. More details about the funding scope can be found here.
This funding competition is part of the Industrial Strategy Challenge Fund (ISCF) for Transforming Foundation Industries and aims to bring businesses from different foundation industries together to work on common resource and energy efficiency opportunities.
Find out more: https://ktn-uk.co.uk/news/iscf-transforming-foundation-industries-fast-start-projects-briefing-events
Commercialising quantum technology, Competition briefing - Chris Jones, Innov...KTN
As part of the Industrial Strategy the Government will invest in the “Commercialising quantum technologies” Industrial Strategy Challenge Fund (ISCF) to enable the UK to lead the global development and application of quantum technologies.
The aim of the competition is to advance the commercialisation of quantum technologies in the UK through the investment of up to £27m in innovation projects.
The webcast recording is now available. Click here to watch it: https://www.youtube.com/watch?v=8beNopMS7sw
Find out more about the Quantum Technologies Special Interest Group at https://ktn-uk.co.uk/interests/quantum-technologies
Join the Quantum Technologies Special Interest Group at https://www.linkedin.com/groups/8594516/
TFI DEMO Competition Briefing & Capability for TFI EventKTN
On Tuesday 12th October 2021, KTN and Innovate UK hosted this event to provide details of the new Transforming Foundation Industries Demonstrators Competition, followed by the Capability for TFI Event where attendees learned about Research Organisations expertise.
https://apply-for-innovation-funding.service.gov.uk/competition/1053/overview
Presentations by Tawfiq Choudhury and Rocco Hadland from the second webinar of the Mastering Cholesterol webinar series on Thursday 11 May 2023, focusing on Statins.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Christopher Geary - Funding: Lancashire SME workshop
1. UK Research and Innovation
Digital Health Technology Catalyst
Round 3
Competition Briefing
25th September 2018
2. UK Research and Innovation
Digital Health Technology Catalyst
The aim of this competition is to speed up the development of new digital solutions to
healthcare challenges and grow the industry.
Projects must focus on the feasibility or development of digital health or digitally-enabled
medical technologies. These MUST have the potential to achieve one or more of the
following:
• improve patient outcomes
• transform healthcare delivery
• enable more efficient delivery of healthcare
These technologies may be designed to be used in both clinical or non-clinical everyday
settings.
Projects must be innovative and clearly demonstrate how they will address needs of the
healthcare system.
3. UK Research and Innovation
*2 grant claiming organisations
All DHTC projects must begin by April 1st 2019
Programme
Competitions
Total Funding available
DHTC 3
Feasibility:
Market and/or technical feasibility
Collaborative R&D:
Industrial research and experimental
development
Up to £1 million Up to £8 million
Total Project Costs £50k - £75k Up to £1 million
Project Duration Up to 12 months
SME led, Collaborative*Project Type SME led, Single or collaborative
12 to 24 months
Overview of the DHTC Round 3 Competition
4. UK Research and Innovation
Feasibility Study Projects
The grant enables the exploration and evaluation of the commercial
and technical potential of an early-stage digital health concept (but not
limited to):
• assessment of the business opportunity
• validation of the initial concept
• scoping for further development
5. UK Research and Innovation
Industrial Research & Experimental Development
Projects
The grant enables the development of new and innovative digital
health solutions, through (but not limited to):
• technology development
• design and prototyping
• demonstration of effectiveness
• market testing
• evaluation
6. UK Research and Innovation
Projects we won’t fund
• don’t have digital technology as the main provider of transformation
• discover or develop medicines
• seek only to develop data or record-keeping systems
• do not demonstrate strong awareness of the underlying unmet need
• are not collaborative (CR&D only)
• are not clearly game-changing or disruptive innovative ideas leading
to novel solutions
7. UK Research and Innovation
Project Collaboration
• Industrial research and experimental development projects must be
collaborative and work with at least one other grant-claiming partner
(NHS, other healthcare providers, other businesses, Catapults or
other research technology organisation, research base or third
sector).
• We recommend that projects collaborate with the NHS on any
industrial research or experimental development project where
appropriate
8. UK Research and Innovation
Timeline Dates
Competition Opened 3 September 2018
Briefing Event 10 September 2018
Submission Deadline 31 October 2018 (12:00 noon)
Interviews (CRD stream only) 7-11 January 2019
Applicants informed 18 January 2019
Key Dates
9. UK Research and Innovation
State aid compliance test
We have introduced a new test to ensure you are able to comply with state aid requirements.
This check is to confirm to us that your organisation is able to sustain itself during the length of the project
This affects organisations that are 3 or more years old
Exempt organisations are:
• RTO’s
• PSO’s
• Companies limited by guarantee
• Academics
• Businesses under 3 years old
Should you be successful and we find this affects your organisation we will be in contact with you.
Further information is available on the website in the general guidance under state aid:
https://www.gov.uk/guidance/innovate-uk-funding-general-guidance-for-applicants#state-aid
Editor's Notes
Sound check –
Thank you for attending the DHTC r3 briefing some of you will be pleased to here we have added in a feasibility stream this is a separate competition so pleased ensure you select the correct competition when you apply
Just to let you know this briefing is being recorded and we will be sending out a copy of the recording and slides after the briefing for you to refer to.
The Digital Health Technology Catalyst has been designed to support SMEs in developing innovative health solutions underpinned by digital technology. The aim of this programme is to speed up the development of new digital solutions to healthcare challenges and grow the industry.
As you know only too well, digital health is evolving at such a rapid pace this is having a profound impact on healthcare delivery. The DHTC is designed to further support the growth in new digital health solutions that have the potential to:
improve patient outcomes;
improve access to healthcare;
make more targeted and personalised health interventions;
transform service delivery;
and to deliver new treatments
We are open to both clinical or non-clinical proposals, but proposals will need to clearly demonstrate how they will address the needs of the healthcare system.
So for feasibility the grant enables the exploration and evaluation of the commercial and technical potential of an early-stage digital health concept. For example through
Assessment of the business opportunity
Validation of the initial concept
Scoping for further development
So on the other side here are some examples of projects that we wouldn’t fund and which may either be excluded or would be marked down by the assessors.
Just to re-iterate, industrial research and experimental projects must be collaborative and we highly encourage collaboration with an NHS organisation.
These are the key dates to bear in mind for this competition. It’s important to note that the submission deadline is at noon on the dot. IFS will automatically close and so at 12:01 applications can’t be submitted. We strongly recommend that you submit your application as early as possible as traffic will be high on deadline day
Please contact customer support in advance of the deadline if you experience any difficulties with submitting your application so that we can assist you in good time
We have recently introduced a new test for successful applicants to ensure they are able to comply with state aid rules. The point of the test it to confirm your organisation is self-sustaining throughout the project.
Organisations that are 3 or more years old will be required to comply with this new test
Exempt organisations are:
RTO’s
PSO’s
Companies limited by guarantee
Academics
Businesses under 3 years old
If you are successful and your organisation is affected by this check we will be in contact with you and advise on next steps